FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: CodeSystem/ATC

Packagedk.kip.rkkp.fhir.ig.core
TypeCodeSystem
IdATC
FHIR VersionR4
Sourcehttps://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/CodeSystem-ATC.html
URLhttps://kip.rkkp.dk/fhir/CodeSystem/ATC
Version2.12.0
Statusactive
Date2022-06-14T00:00:00+02:00
NameATC
TitleWHO ATC
DescriptionWHO ATC code system. Link: http://www.whocc.no/atc
Contentfragment

Resources that use this resource

ValueSet
ATCAntibiotikaprofylakseDKRATC - Antibiotikaprofylakse (DKR)
ATCChemoCLLATC_CLL_kemo
ATCChemoPreparationATC: Præparater for kemobehandling
ATCDMPNATC DMPN
ATCDMPN202410ATC DMPN 202410
ATCImmunotherapyCLLATC_CLL_immunterapi
ATCTargetCLLATC_CLL_target
ATCTromboseprofylakseDKRATC - Tromboseprofylakse (DKR)
AntibiotikaprofylakseDHRAntibiotikaprofylakse (DHR)
AntibiotikaprofylakseDKRRAntibiotikaprofylakse (DKRR)
BehandlingCMLBehandling (CML)
BehandlingCMMLMDSBehandlinger foretaget i forbindelse med CMML (MDS)
BehandlingMDSBehandlinger foretaget i forbindelse med MDS (MDS)
BehandlingsTypeStamcellestoetteLYFOBehandlingsttype - Stamcellestøtte (LYFO)
BloedningsprofylakseDHRBlødningsprofylakse (DHR)
ImmunoterapiImmunoterapi
KemoterapiregimeKemoterapiregime
RadioimmunoterapiRadioimmunoterapi
TreatmentPreservationVedligeholdelsesbehandling
TreatmentScheduledDAMYDAPlanlagt behandling (DAMYDA)

Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: CodeSystem ATC

This case-sensitive code system https://kip.rkkp.dk/fhir/CodeSystem/ATC provides a fragment that includes following codes in an undefined hierarchy:

LvlCodeDisplayDefinition
1B01A ANTITHROMBOTIC AGENTSB01A - ANTITHROMBOTIC AGENTS
2  B01AA03 warfarinB01AA03 - warfarin
2  B01AB01 heparinB01AB01 - heparin
2  B01AB04 dalteparinB01AB04 - dalteparin
2  B01AB05 enoxaparinB01AB05 - enoxaparin
2  B01AB10 tinzaparinB01AB10 - tinzaparin
2  B01AC06 acetylsalicylic acidB01AC06 - acetylsalicylic acid
2  B01AE07 dabigatran etexilateB01AE07 - dabigatran etexilate
2  B01AF01 rivaroxabanB01AF01 - rivaroxaban
2  B01AF02 apixabanB01AF02 - apixaban
2  B01AX05 fondaparinuxB01AX05 - fondaparinux
1B02AA02 tranexamic acidB02AA02 - Tranexamic acid
1B03XA01 erythropoietinB03XA01 - erythropoietin
1C10AA HMG CoA reductase inhibitorsC10AA - HMG CoA reductase inhibitors
1H02 CORTICOSTEROIDS FOR SYSTEMIC USEH02 - CORTICOSTEROIDS FOR SYSTEMIC USE
1J01CF01 dicloxacillinJ01CF01 - dicloxacillin
1J01CF02 cloxacillinJ01CF02 - cloxacillin
1J01CF03 meticillinJ01CF03 - meticillin
1J01CF05 flucloxacillinJ01CF05 - flucloxacillin
1J01DB01 cefalexinJ01DB01 - cefalexin
1J01DB03 cefalotinJ01DB03 - cefalotin
1J01DC02 cefuroximeJ01DC02 - cefuroxime
1J01FA01 erythromycinJ01FA01 - erythromycin
1J01GB03 gentamicinJ01GB03 - gentamicin
1J01XA01 vancomycinJ01XA01 - vancomycin
1L01AA01 cyclophosphamideL01AA01 - cyclophosphamide
1L01AA02 chlorambucilL01AA02 - chlorambucil
1L01AA03 melphalanL01AA03 - melphalan
1L01AA06 ifosfamideL01AA06 - ifosfamide
1L01AA09 bendamustineL01AA09 - bendamustine
1L01AB01 busulfanL01AB01 - busulfan
1L01AC01 thiotepaL01AC01 thiotepa
1L01AD01 carmustineL01AD01 - carmustine
1L01AX03 temozolomideL01AX03 - temozolomide
1L01AX04 dacarbazineL01AX04 - dacarbazine
1L01BB05 fludarabineL01BB05 - fludarabine
1L01BC02 fluorouracilL01BC02 - Fluorouracil (5-FU)
1L01BC05 gemcitabineL01BC02 - Gemcitabine
1L01BC06 capecitabineL01BC06 - Capecitabine
1L01BC07 azacitidineL01BC07 - azacitidine
1L01CA02 vincristineL01CA02 - vincristine
1L01CA04 vinorelbineL01CA04 - Vinorelbine
1L01CB01 etoposideL01CB01 - etoposide
1L01CD01 paclitaxelL01CD01 - Paclitaxel
1L01CD02 docetaxelL01CD02 - Docetaxel
1L01CE02 irinotecanL01CE02 - Irinotecan
1L01DB01 doxorubicinL01DB01 - Doxorubicin
1L01DB03 epirubicinL01DB03 - Epirubicin
1L01DB07 mitoxantroneL01DB07 - mitoxantrone
1L01DB11 pixantroneL01DB11 - pixantrone
1L01DC01 bleomycinL01DC01 - bleomycin
1L01EA BCR-ABL tyrosine kinase inhibitors
2  L01EA01 imatinibL01EA01 - imatinib
2  L01EA02 dasatinibL01EA02 - dasatinib
2  L01EA03 nilotinibL01EA03 - nilotinib
2  L01EA04 bosutinibL01EA04 - bosutinib
2  L01EA05 ponatinibL01EA05 - ponatinib
2  L01EA06 AsciminibL01EA06 - Asciminib
1L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitorsL01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
1L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitorsL01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors
1L01EJ Janus-associated kinase (JAK) inhibitorsJanus associerede kinase (JAK) hæmmere
2  L01EJ01 ruxolitinibL01EJ01 - ruxolitinib
1L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitorsL01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
1L01EL01 ibrutinibL01EL01 - ibrutinib
1L01EL02 acalabrutinibL01EL02 - acalabrutinib
1L01EM01 idelalisibL01EM01 - idelalisib
1L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitorsL01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
1L01FA01 rituximabL01FA01 - rituximab
1L01FA02 ofatumumabL01FA02 - ofatumumab
1L01FA03 obinutuzumabL01FA03 - obinutuzumab
1L01FC01 daratumumabL01FC01 - daratumumab
1L01FC02 isatuximabL01FC02 - isatuximab
1L01FD01 trastuzumabL01FD01 - Trastuzumab
1L01FF PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitorsL01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
2  L01FF01 nivolumabL01FF01 - Nivolumab
2  L01FF02 pembrolizumabL01FF02 - Pembrolizumab
1L01FG01 bevacizumabL01FG01 - Bevacizumab
1L01FX05 brentuximab vedotinL01FX05 - brentuximab vedotin
1L01FX08 elotuzumabL01FX08 - elotuzumab
1L01FX14 polatuzumab vedotinL01FX14 - polatuzumab vedotin
1L01XA01 cisplatinL01XA01 - Cisplatin
1L01XA02 carboplatinL01XA02 - Carboplatin
1L01XA03 oxaliplatinL01XA03 - Oxaliplatin
1L01XG01 bortezomibL01XG01 - bortezomib
1L01XG02 carfilzomibL01XG02 - carfilzomib
1L01XG03 ixazomibL01XG03 - ixazomib
1L01XH Histone deacetylase (HDAC) inhibitorsL01XH - Histone deacetylase (HDAC) inhibitors
2  L01XH01 vorinostatL01XH01 - vorinostat
2  L01XH03 panobinostatL01XH03 - panobinostat
1L01XX05 hydroxycarbamideL01XX05 - hydroxycarbamide
1L01XX35 anagrelideL01XX35 - anagrelide
1L01XX52 venetoclaxL01XX52 - venetoclax
1L03AB InterferonsL03AB - Interferons
1L04A IMMUNOSUPPRESSANTSL04A - IMMUNOSUPPRESSANTS
2  L04AA Selective immunosuppressantsL04AA - Selective immunosuppressants
3    L04AA34 alemtuzumabL04AA34 - alemtuzumab
3    L04AA40 cladribineL04AA40 - cladribine
1L04AD01 ciclosporinL04AD01 - ciclosporin
1L04AX02 thalidomideL04AX02 - thalidomide
1L04AX04 lenalidomideL04AX04 - lenalidomide
1L04AX06 pomalidomideL04AX06 - pomalidomide
1M05BA03 pamidronic acidM05BA03 - pamidronic acid
1M05BA08 zoledronic acidM05BA08 - zoledronic acid
1M05BX04 denosumabM05BX04 - denosumab
1S01LA08 bevacizumabS01LA08 - Bevacizumab
1V10X OTHER THERAPEUTIC RADIOPHARMACEUTICALSV10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS
2  V10XA53 tositumomab/iodine (131I) tositumomabV10XA53 - tositumomab/iodine (131I) tositumomab
2  V10XX02 ibritumomab tiuxetan (90Y)V10XX02 - ibritumomab tiuxetan (90Y)

Source

{
  "resourceType": "CodeSystem",
  "id": "ATC",
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "url": "https://kip.rkkp.dk/fhir/CodeSystem/ATC",
  "identifier": [
    {
      "value": "urn:oid:2.16.840.1.113883.6.73"
    }
  ],
  "version": "2.12.0",
  "name": "ATC",
  "title": "WHO ATC",
  "status": "active",
  "date": "2022-06-14T00:00:00+02:00",
  "publisher": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
  "contact": [
    {
      "name": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
      "telecom": [
        {
          "system": "url",
          "value": "https://trifork.com"
        },
        {
          "system": "email",
          "value": "rbk@trifork.com"
        }
      ]
    }
  ],
  "description": "WHO ATC code system. Link: http://www.whocc.no/atc",
  "caseSensitive": true,
  "content": "fragment",
  "concept": [
    {
      "code": "B01A",
      "display": "ANTITHROMBOTIC AGENTS",
      "definition": "B01A - ANTITHROMBOTIC AGENTS",
      "concept": [
        {
          "code": "B01AA03",
          "display": "warfarin",
          "definition": "B01AA03 - warfarin"
        },
        {
          "code": "B01AB01",
          "display": "heparin",
          "definition": "B01AB01 - heparin"
        },
        {
          "code": "B01AB04",
          "display": "dalteparin",
          "definition": "B01AB04 - dalteparin"
        },
        {
          "code": "B01AB05",
          "display": "enoxaparin",
          "definition": "B01AB05 - enoxaparin"
        },
        {
          "code": "B01AB10",
          "display": "tinzaparin",
          "definition": "B01AB10 - tinzaparin"
        },
        {
          "code": "B01AC06",
          "display": "acetylsalicylic acid",
          "definition": "B01AC06 - acetylsalicylic acid"
        },
        {
          "code": "B01AE07",
          "display": "dabigatran etexilate",
          "definition": "B01AE07 - dabigatran etexilate"
        },
        {
          "code": "B01AF01",
          "display": "rivaroxaban",
          "definition": "B01AF01 - rivaroxaban"
        },
        {
          "code": "B01AF02",
          "display": "apixaban",
          "definition": "B01AF02 - apixaban"
        },
        {
          "code": "B01AX05",
          "display": "fondaparinux",
          "definition": "B01AX05 - fondaparinux"
        }
      ]
    },
    {
      "code": "B02AA02",
      "display": "tranexamic acid",
      "definition": "B02AA02 - Tranexamic acid"
    },
    {
      "code": "B03XA01",
      "display": "erythropoietin",
      "definition": "B03XA01 - erythropoietin"
    },
    {
      "code": "C10AA",
      "display": "HMG CoA reductase inhibitors",
      "definition": "C10AA - HMG CoA reductase inhibitors"
    },
    {
      "code": "H02",
      "display": "CORTICOSTEROIDS FOR SYSTEMIC USE",
      "definition": "H02 - CORTICOSTEROIDS FOR SYSTEMIC USE"
    },
    {
      "code": "J01CF01",
      "display": "dicloxacillin",
      "definition": "J01CF01 - dicloxacillin"
    },
    {
      "code": "J01CF02",
      "display": "cloxacillin",
      "definition": "J01CF02 - cloxacillin"
    },
    {
      "code": "J01CF03",
      "display": "meticillin",
      "definition": "J01CF03 - meticillin"
    },
    {
      "code": "J01CF05",
      "display": "flucloxacillin",
      "definition": "J01CF05 - flucloxacillin"
    },
    {
      "code": "J01DB01",
      "display": "cefalexin",
      "definition": "J01DB01 - cefalexin"
    },
    {
      "code": "J01DB03",
      "display": "cefalotin",
      "definition": "J01DB03 - cefalotin"
    },
    {
      "code": "J01DC02",
      "display": "cefuroxime",
      "definition": "J01DC02 - cefuroxime"
    },
    {
      "code": "J01FA01",
      "display": "erythromycin",
      "definition": "J01FA01 - erythromycin"
    },
    {
      "code": "J01GB03",
      "display": "gentamicin",
      "definition": "J01GB03 - gentamicin"
    },
    {
      "code": "J01XA01",
      "display": "vancomycin",
      "definition": "J01XA01 - vancomycin"
    },
    {
      "code": "L01AA01",
      "display": "cyclophosphamide",
      "definition": "L01AA01 - cyclophosphamide"
    },
    {
      "code": "L01AA02",
      "display": "chlorambucil",
      "definition": "L01AA02 - chlorambucil"
    },
    {
      "code": "L01AA03",
      "display": "melphalan",
      "definition": "L01AA03 - melphalan"
    },
    {
      "code": "L01AA06",
      "display": "ifosfamide",
      "definition": "L01AA06 - ifosfamide"
    },
    {
      "code": "L01AA09",
      "display": "bendamustine",
      "definition": "L01AA09 - bendamustine"
    },
    {
      "code": "L01AB01",
      "display": "busulfan",
      "definition": "L01AB01 - busulfan"
    },
    {
      "code": "L01AC01",
      "display": "thiotepa",
      "definition": "L01AC01 thiotepa"
    },
    {
      "code": "L01AD01",
      "display": "carmustine",
      "definition": "L01AD01 - carmustine"
    },
    {
      "code": "L01AX03",
      "display": "temozolomide",
      "definition": "L01AX03 - temozolomide"
    },
    {
      "code": "L01AX04",
      "display": "dacarbazine",
      "definition": "L01AX04 - dacarbazine"
    },
    {
      "code": "L01BB05",
      "display": "fludarabine",
      "definition": "L01BB05 - fludarabine"
    },
    {
      "code": "L01BC02",
      "display": "fluorouracil",
      "definition": "L01BC02 - Fluorouracil (5-FU)"
    },
    {
      "code": "L01BC05",
      "display": "gemcitabine",
      "definition": "L01BC02 - Gemcitabine"
    },
    {
      "code": "L01BC06",
      "display": "capecitabine",
      "definition": "L01BC06 - Capecitabine"
    },
    {
      "code": "L01BC07",
      "display": "azacitidine",
      "definition": "L01BC07 - azacitidine"
    },
    {
      "code": "L01CA02",
      "display": "vincristine",
      "definition": "L01CA02 - vincristine"
    },
    {
      "code": "L01CA04",
      "display": "vinorelbine",
      "definition": "L01CA04 - Vinorelbine"
    },
    {
      "code": "L01CB01",
      "display": "etoposide",
      "definition": "L01CB01 - etoposide"
    },
    {
      "code": "L01CD01",
      "display": "paclitaxel",
      "definition": "L01CD01 - Paclitaxel"
    },
    {
      "code": "L01CD02",
      "display": "docetaxel",
      "definition": "L01CD02 - Docetaxel"
    },
    {
      "code": "L01CE02",
      "display": "irinotecan",
      "definition": "L01CE02 - Irinotecan"
    },
    {
      "code": "L01DB01",
      "display": "doxorubicin",
      "definition": "L01DB01 - Doxorubicin"
    },
    {
      "code": "L01DB03",
      "display": "epirubicin",
      "definition": "L01DB03 - Epirubicin"
    },
    {
      "code": "L01DB07",
      "display": "mitoxantrone",
      "definition": "L01DB07 - mitoxantrone"
    },
    {
      "code": "L01DB11",
      "display": "pixantrone",
      "definition": "L01DB11 - pixantrone"
    },
    {
      "code": "L01DC01",
      "display": "bleomycin",
      "definition": "L01DC01 - bleomycin"
    },
    {
      "code": "L01EA",
      "display": "BCR-ABL tyrosine kinase inhibitors",
      "concept": [
        {
          "code": "L01EA01",
          "display": "imatinib",
          "definition": "L01EA01 - imatinib"
        },
        {
          "code": "L01EA02",
          "display": "dasatinib",
          "definition": "L01EA02 - dasatinib"
        },
        {
          "code": "L01EA03",
          "display": "nilotinib",
          "definition": "L01EA03 - nilotinib"
        },
        {
          "code": "L01EA04",
          "display": "bosutinib",
          "definition": "L01EA04 - bosutinib"
        },
        {
          "code": "L01EA05",
          "display": "ponatinib",
          "definition": "L01EA05 - ponatinib"
        },
        {
          "code": "L01EA06",
          "display": "Asciminib",
          "definition": "L01EA06 - Asciminib"
        }
      ]
    },
    {
      "code": "L01EB",
      "display": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
      "definition": "L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors"
    },
    {
      "code": "L01EH",
      "display": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors",
      "definition": "L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors"
    },
    {
      "code": "L01EJ",
      "display": "Janus-associated kinase (JAK) inhibitors",
      "definition": "Janus associerede kinase (JAK) hæmmere",
      "concept": [
        {
          "code": "L01EJ01",
          "display": "ruxolitinib",
          "definition": "L01EJ01 - ruxolitinib"
        }
      ]
    },
    {
      "code": "L01EK",
      "display": "Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors",
      "definition": "L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors"
    },
    {
      "code": "L01EL01",
      "display": "ibrutinib",
      "definition": "L01EL01 - ibrutinib"
    },
    {
      "code": "L01EL02",
      "display": "acalabrutinib",
      "definition": "L01EL02 - acalabrutinib"
    },
    {
      "code": "L01EM01",
      "display": "idelalisib",
      "definition": "L01EM01 - idelalisib"
    },
    {
      "code": "L01EN",
      "display": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
      "definition": "L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors"
    },
    {
      "code": "L01FA01",
      "display": "rituximab",
      "definition": "L01FA01 - rituximab"
    },
    {
      "code": "L01FA02",
      "display": "ofatumumab",
      "definition": "L01FA02 - ofatumumab"
    },
    {
      "code": "L01FA03",
      "display": "obinutuzumab",
      "definition": "L01FA03 - obinutuzumab"
    },
    {
      "code": "L01FC01",
      "display": "daratumumab",
      "definition": "L01FC01 - daratumumab"
    },
    {
      "code": "L01FC02",
      "display": "isatuximab",
      "definition": "L01FC02 - isatuximab"
    },
    {
      "code": "L01FD01",
      "display": "trastuzumab",
      "definition": "L01FD01 - Trastuzumab"
    },
    {
      "code": "L01FF",
      "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
      "definition": "L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
      "concept": [
        {
          "code": "L01FF01",
          "display": "nivolumab",
          "definition": "L01FF01 - Nivolumab"
        },
        {
          "code": "L01FF02",
          "display": "pembrolizumab",
          "definition": "L01FF02 - Pembrolizumab"
        }
      ]
    },
    {
      "code": "L01FG01",
      "display": "bevacizumab",
      "definition": "L01FG01 - Bevacizumab"
    },
    {
      "code": "L01FX05",
      "display": "brentuximab vedotin",
      "definition": "L01FX05 - brentuximab vedotin"
    },
    {
      "code": "L01FX08",
      "display": "elotuzumab",
      "definition": "L01FX08 - elotuzumab"
    },
    {
      "code": "L01FX14",
      "display": "polatuzumab vedotin",
      "definition": "L01FX14 - polatuzumab vedotin"
    },
    {
      "code": "L01XA01",
      "display": "cisplatin",
      "definition": "L01XA01 - Cisplatin"
    },
    {
      "code": "L01XA02",
      "display": "carboplatin",
      "definition": "L01XA02 - Carboplatin"
    },
    {
      "code": "L01XA03",
      "display": "oxaliplatin",
      "definition": "L01XA03 - Oxaliplatin"
    },
    {
      "code": "L01XG01",
      "display": "bortezomib",
      "definition": "L01XG01 - bortezomib"
    },
    {
      "code": "L01XG02",
      "display": "carfilzomib",
      "definition": "L01XG02 - carfilzomib"
    },
    {
      "code": "L01XG03",
      "display": "ixazomib",
      "definition": "L01XG03 - ixazomib"
    },
    {
      "code": "L01XH",
      "display": "Histone deacetylase (HDAC) inhibitors",
      "definition": "L01XH - Histone deacetylase (HDAC) inhibitors",
      "concept": [
        {
          "code": "L01XH01",
          "display": "vorinostat",
          "definition": "L01XH01 - vorinostat"
        },
        {
          "code": "L01XH03",
          "display": "panobinostat",
          "definition": "L01XH03 - panobinostat"
        }
      ]
    },
    {
      "code": "L01XX05",
      "display": "hydroxycarbamide",
      "definition": "L01XX05 - hydroxycarbamide"
    },
    {
      "code": "L01XX35",
      "display": "anagrelide",
      "definition": "L01XX35 - anagrelide"
    },
    {
      "code": "L01XX52",
      "display": "venetoclax",
      "definition": "L01XX52 - venetoclax"
    },
    {
      "code": "L03AB",
      "display": "Interferons",
      "definition": "L03AB - Interferons"
    },
    {
      "code": "L04A",
      "display": "IMMUNOSUPPRESSANTS",
      "definition": "L04A - IMMUNOSUPPRESSANTS",
      "concept": [
        {
          "code": "L04AA",
          "display": "Selective immunosuppressants",
          "definition": "L04AA - Selective immunosuppressants",
          "concept": [
            {
              "code": "L04AA34",
              "display": "alemtuzumab",
              "definition": "L04AA34 - alemtuzumab"
            },
            {
              "code": "L04AA40",
              "display": "cladribine",
              "definition": "L04AA40 - cladribine"
            }
          ]
        }
      ]
    },
    {
      "code": "L04AD01",
      "display": "ciclosporin",
      "definition": "L04AD01 - ciclosporin"
    },
    {
      "code": "L04AX02",
      "display": "thalidomide",
      "definition": "L04AX02 - thalidomide"
    },
    {
      "code": "L04AX04",
      "display": "lenalidomide",
      "definition": "L04AX04 - lenalidomide"
    },
    {
      "code": "L04AX06",
      "display": "pomalidomide",
      "definition": "L04AX06 - pomalidomide"
    },
    {
      "code": "M05BA03",
      "display": "pamidronic acid",
      "definition": "M05BA03 - pamidronic acid"
    },
    {
      "code": "M05BA08",
      "display": "zoledronic acid",
      "definition": "M05BA08 - zoledronic acid"
    },
    {
      "code": "M05BX04",
      "display": "denosumab",
      "definition": "M05BX04 - denosumab"
    },
    {
      "code": "S01LA08",
      "display": "bevacizumab",
      "definition": "S01LA08 - Bevacizumab"
    },
    {
      "code": "V10X",
      "display": "OTHER THERAPEUTIC RADIOPHARMACEUTICALS",
      "definition": "V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS",
      "concept": [
        {
          "code": "V10XA53",
          "display": "tositumomab/iodine (131I) tositumomab",
          "definition": "V10XA53 - tositumomab/iodine (131I) tositumomab"
        },
        {
          "code": "V10XX02",
          "display": "ibritumomab tiuxetan (90Y)",
          "definition": "V10XX02 - ibritumomab tiuxetan (90Y)"
        }
      ]
    }
  ]
}